Atara Biotherapeutics Inc  

(Public, NASDAQ:ATRA)   Watch this stock  
Find more results for John T. Isaacs, Ph.D.�
-0.46 (-1.95%)
Jan 23 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 23.03 - 25.00
52 week 9.66 - 35.45
Open 23.75
Vol / Avg. 18,929.00/108,555.00
Mkt cap 467.73M
P/E     -
Div/yield     -
EPS     -
Shares 20.21M
Beta     -
Inst. own 55%

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -42.16% -31.27%
Return on average equity - -
Employees 14 -
CDP Score - -


3260 Bayshore Blvd
BRISBANE, CA 94005-1021
United States - Map
+1-415-2872410 (Phone)
+1-302-5313150 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. The Company�s product candidates are biologics targeting myostatin and activin, members of the Transforming Growth Factor-Beta (TGF-B), protein superfamily, which play roles in the growth and maintenance of muscle and many other body tissues. The Company�s lead product candidate, PINTA 745, is in a Phase II clinical trial for protein-energy wasting, a condition affecting many end-stage renal disease patients. Its second product candidate is STM 434. The Company has five additional molecules in preclinical development.

Officers and directors

Isaac E. Ciechanover M.D. President, Chief Executive Officer, Director
Age: 43
Bio & Compensation  - Reuters
John F. McGrath Jr. Chief Financial Officer
Age: 49
Bio & Compensation  - Reuters
Gad Soffer Chief Operating Officer
Age: 37
Bio & Compensation  - Reuters
Mitchall G Clark Chief Regulatory and Quality Assurance Officer
Age: 53
Bio & Compensation  - Reuters
Christopher M. Haqq M.D., Ph.D. Chief Medical Officer
Age: 48
Bio & Compensation  - Reuters
Carol G. Gallagher Lead Independent Director
Bio & Compensation  - Reuters
Matthew K Fust Independent Director
Age: 50
Bio & Compensation  - Reuters
Joel S. Marcus J.D., CPA. Independent Director
Age: 66
Bio & Compensation  - Reuters
Beth C. Seidenberg M.D. Independent Director
Age: 55
Bio & Compensation  - Reuters